These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 18181086

  • 1. Dietary therapy in polycystic ovary syndrome.
    Moran LJ, Brinkworth GD, Norman RJ.
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [Abstract] [Full Text] [Related]

  • 2. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.
    Moran L, Norman RJ.
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):719-36. PubMed ID: 15380143
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 4. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 5. Exercise therapy in polycystic ovary syndrome.
    Hoeger KM.
    Semin Reprod Med; 2008 Jan; 26(1):93-100. PubMed ID: 18181087
    [Abstract] [Full Text] [Related]

  • 6. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 7. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
    Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ.
    Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
    [Abstract] [Full Text] [Related]

  • 8. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [Abstract] [Full Text] [Related]

  • 9. Obesity and lifestyle management in polycystic ovary syndrome.
    Hoeger KM.
    Clin Obstet Gynecol; 2007 Mar; 50(1):277-94. PubMed ID: 17304042
    [Abstract] [Full Text] [Related]

  • 10. Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management.
    Farshchi H, Rane A, Love A, Kennedy RL.
    J Obstet Gynaecol; 2007 Nov; 27(8):762-73. PubMed ID: 18097891
    [Abstract] [Full Text] [Related]

  • 11. Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet.
    O'Connor A, Gibney J, Roche HM.
    Proc Nutr Soc; 2010 Nov; 69(4):628-35. PubMed ID: 20696094
    [Abstract] [Full Text] [Related]

  • 12. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L, Teede H.
    Hum Reprod Update; 2009 Nov; 15(4):477-88. PubMed ID: 19279045
    [Abstract] [Full Text] [Related]

  • 13. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
    Nybacka Å, Carlström K, Ståhle A, Nyrén S, Hellström PM, Hirschberg AL.
    Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
    [Abstract] [Full Text] [Related]

  • 14. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ, Hutchison SK, Zoungas S.
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [Abstract] [Full Text] [Related]

  • 15. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
    Thomson RL, Buckley JD, Brinkworth GD.
    Obes Rev; 2011 May; 12(5):e202-10. PubMed ID: 20546140
    [Abstract] [Full Text] [Related]

  • 16. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study.
    Qublan HS, Yannakoula EK, Al-Qudah MA, El-Uri FI.
    Saudi Med J; 2007 Nov; 28(11):1694-9. PubMed ID: 17965792
    [Abstract] [Full Text] [Related]

  • 17. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E.
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [Abstract] [Full Text] [Related]

  • 18. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A, Amato MC, Giordano C.
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [Abstract] [Full Text] [Related]

  • 19. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG.
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [Abstract] [Full Text] [Related]

  • 20. Lifestyle and Behavioral Management of Polycystic Ovary Syndrome.
    Brennan L, Teede H, Skouteris H, Linardon J, Hill B, Moran L.
    J Womens Health (Larchmt); 2017 Aug; 26(8):836-848. PubMed ID: 28570835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.